ArticleTranslational cancer research2026
Construction and validation of a prognostic model associated with chromatin remodeling in hepatocellular carcinoma.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Abnormal chromatin remodeling figures prominently in the progression and treatment of malignancies. However, the prognostic significance of chromatin remodeling-related genes (CRRGs) in hepatocellular carcinoma (HCC) has not been extensively examined. Therefore, this study aimed to identify prognostic genes associated with chromatin remodeling in HCC and to determine their prognostic significance. Methods: Differential expression analysis was conducted on The Cancer Genome Atlas-liver hepatocellular carcinoma (TCGA-LIHC) dataset to identify differentially expressed genes (DEGs). By overlapping DEGs with CRRGs and performing enrichment analysis, we identified chromatin remodeling-related DEGs (CRR-DEGs). Risk models were developed via least absolute shrinkage and selection operator (LASSO) and Cox regression analyses and were validated in International Cancer Genome Consortium Liver Cancer-RIKEN, Japan (ICGC-LIRI-JP) dataset. Independent prognostic factors were screened out according to risk scores and clinical indicators, and a nomogram was created. Additional analysis included survival, expression, mutation, enrichment, and regulatory network predictions. Results: Eighteen CRR-DEGs were identified through the intersection of DEGs and CRRGs, all of which were found to be enriched in adenosine triphosphate (ATP)-dependent chromatin remodeling pathways, and eight of which were found to be specifically enriched in HCC. Four prognostic genes ( Conclusions: Four prognostic genes associated with chromatin remodeling in HCC were identified, and a prognostic model for HCC was established, offering valuable insights for the development of HCC treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.